Cargando…
Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury
Hepatitis C virus (HCV)-induced inflammation contributes to progressive liver disease. The chemoattractant protein chemerin is associated with systemic inflammation. We hypothesized that chemerin is a biomarker that predicts the severity of liver disease in HCV patients. Furthermore, we investigated...
Autores principales: | Peschel, Georg, Grimm, Jonathan, Gülow, Karsten, Müller, Martina, Buechler, Christa, Weigand, Kilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699464/ https://www.ncbi.nlm.nih.gov/pubmed/33228201 http://dx.doi.org/10.3390/diagnostics10110974 |
Ejemplares similares
-
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV
por: Weigand, Kilian, et al.
Publicado: (2022) -
Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection
por: Peschel, Georg, et al.
Publicado: (2022) -
Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection
por: Höring, Marcus, et al.
Publicado: (2022) -
Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients
por: Peschel, Georg, et al.
Publicado: (2023) -
Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy
por: Grimm, Jonathan, et al.
Publicado: (2021)